Emerging role of stereotactic body radiotherapy in the treatment of pancreatic cancer
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Emerging role of stereotactic body radiotherapy in the treatment of pancreatic cancer
Authors
Keywords
-
Journal
Expert Review of Anticancer Therapy
Volume 13, Issue 4, Pages 481-487
Publisher
Informa UK Limited
Online
2013-04-08
DOI
10.1586/era.13.19
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cancer statistics, 2012
- (2012) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Palliative resections versus palliative bypass procedures in pancreatic cancer—a systematic review
- (2011) Sonja Gillen et al. AMERICAN JOURNAL OF SURGERY
- Fluorouracil-based Chemoradiation with Either Gemcitabine or Fluorouracil Chemotherapy after Resection of Pancreatic Adenocarcinoma: 5-Year Analysis of the U.S. Intergroup/RTOG 9704 Phase III Trial
- (2011) William F. Regine et al. ANNALS OF SURGICAL ONCOLOGY
- Single-Fraction Stereotactic Body Radiation Therapy and Sequential Gemcitabine for the Treatment of Locally Advanced Pancreatic Cancer
- (2011) Devin Schellenberg et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Treatment of Locally Advanced Pancreatic Cancer: The Role of Radiation Therapy
- (2011) Kimberly Johung et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Gemcitabine Alone Versus Gemcitabine Plus Radiotherapy in Patients With Locally Advanced Pancreatic Cancer: An Eastern Cooperative Oncology Group Trial
- (2011) Patrick J. Loehrer et al. JOURNAL OF CLINICAL ONCOLOGY
- Stereotactic Body Radiation Therapy for Nonresectable Tumors of the Pancreas
- (2011) Kush Goyal et al. JOURNAL OF SURGICAL RESEARCH
- EUS-guided fiducial placement for stereotactic body radiotherapy in locally advanced and recurrent pancreatic cancer
- (2010) Michael K. Sanders et al. GASTROINTESTINAL ENDOSCOPY
- Stereotactic Body Radiotherapy and Gemcitabine for Locally Advanced Pancreatic Cancer
- (2010) Anand Mahadevan et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- A Generalized Linear-Quadratic Model for Radiosurgery, Stereotactic Body Radiation Therapy, and High-Dose Rate Brachytherapy
- (2010) J. Z. Wang et al. Science Translational Medicine
- Chemoradiotherapy with concurrent gemcitabine and cisplatin with or without sequential chemotherapy with gemcitabine/cisplatin vs chemoradiotherapy with concurrent 5-fluorouracil in patients with locally advanced pancreatic cancer – a multi-centre randomised phase II study
- (2009) R Wilkowski et al. BRITISH JOURNAL OF CANCER
- Stereotactic radiotherapy for unresectable adenocarcinoma of the pancreas
- (2009) Daniel T. Chang et al. CANCER
- Classification of R1 resections for pancreatic cancer: the prognostic relevance of tumour involvement within 1 mm of a resection margin
- (2009) Fiona Campbell et al. HISTOPATHOLOGY
- Stereotactic Body Radiation Therapy Boost in Locally Advanced Pancreatic Cancer
- (2009) YoungSeok Seo et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- External Beam Radiotherapy Plus 24-Hour Continuous Infusion of Gemcitabine in Unresectable Pancreatic Carcinoma: Long-Term Results of a Phase II Study
- (2009) Gian C. Mattiucci et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Phase II Study of Bevacizumab With Concurrent Capecitabine and Radiation Followed by Maintenance Gemcitabine and Bevacizumab for Locally Advanced Pancreatic Cancer: Radiation Therapy Oncology Group RTOG 0411
- (2009) Christopher H. Crane et al. JOURNAL OF CLINICAL ONCOLOGY
- Stereotactic body radiation therapy: a novel treatment modality
- (2009) Simon S. Lo et al. Nature Reviews Clinical Oncology
- Universal Survival Curve and Single Fraction Equivalent Dose: Useful Tools in Understanding Potency of Ablative Radiotherapy
- (2008) Clint Park et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started